Regarding "Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea"

J S Mertens1, E M G J de Jong2, A Pandit3

  • 1Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.

Abstract

No abstract available in PubMed .